Cannizzo, Paola Maria Loredana

Consolandi, Giulia

Fea, Antonio Maria

Lavia, Carlo Alessandro

Pignata, Giulia

Rolle, Teresa

English

Cannizzo, PAOLA MARIA LOREDANA

Institutional Research Information System University of Turin

FREEARVO Annual Meeting Abstract  |   June 2015Is trabecular sugery (Hydrus-Ivantis) really safe?Operative and post-operative complications of a singlesite clinical groupAntonio Maria Fea; Giulia Consolandi; Paola cannizzo; giulia pignata; Carlo Lavia; Teresa Rolle  Author Affiliations & NotesInvestigative Ophthalmology & Visual Science June 2015, Vol.56, 2684. doi:AbstractPurpose: Trabecular surgery has been introduced to overcome the complications of traditional glaucoma surgery(trabeculectomy, shunt surgery). To evaluate clinically the number and type of complications of a new trabecularbypass in a one site clinical group of phakic patients.Methods: Intraoperative complications of phakic patients undergoing consecutive trabecular stent implantation(Hydrus-Ivantis) by a single surgeon were evaluated. The patients were evaluated at 1 month, 3 months and at 1year considering visual acuity, visual field, and gonioscopy.Results: 41 caucasic patients (12 males and 29 females) with a mean age of 67.4 ± 8.5 years (range: 49-84) wereincluded in the study. All patients had a diagnosis of primary open angle glaucoma with a mean visual field MD of-4.4 and a PSD of 4.3. The mean cup to disk ratio was 0.7 ± 0.2. Pre-operative BCVA was 20/23, the meanmedicated IOP was 19.8± 3.4 and the mean number of medications was 1.6. At the end of surgery two patientspresented a hyphema (>2mm). In one patient, the stent was repositioned during the surgical procedure. 36patients were followed up to 3 months and 33 up to one year. The IOP decreased to 17,5 ± 3.3 at three monthsand to 18 ± 3.2 at one year. At 3 months 19,4% and at one year 42,4% of the patients were medicated (meannumber of medications: 0.4 and 0.9 respectively). During the follow up no patient had a BCVA loss ≥ 2 Snellenlines. Cup disk ratio and visual field MD were not statistically significant compared to baseline. In 6 patients newperipheral anterior synechiae (PAS) were observed. The occurrence of PAS did not modify the IOP nor requiredadditional medical or surgical therapy.Conclusions: The Hydrus trabecular stent allowed a significant reduction of therapy in this group of phakicpatients, with 57,6% unmedicated patients up to one year. The mean number of medications decreasedsignificantly compared to baseline (1.6 vs 0.9; p<0.05). Mild intraocular complications were observed. During thefollow-up, some patients developed peripheral anterior synechiae which did not seem to be clinically significant.The Association for Research in Vision and OphthalmologyIs trabecular sugery (Hydrus-Ivantis) really safe? Operative and post-o... http://iovs.arvojournals.org/article.aspx?articleid=2332475&resultClick=11 di 1 27/06/2016 15:01

Is trabecular sugery (Hydrus-Ivantis) really safe? Operative and post-operative complications of a single site clinical group

https://iris.unito.it/bitstream/2318/1572973/1/Is%20trabecular%20sugery%20%28Hydrus-Ivantis%29%20really%20safe_.pdf

Is trabecular sugery (Hydrus-Ivantis) really safe? Operative and post-operative complications of a single site clinical group

Abstract

Similar works

Full text

Available Versions

Institutional Research Information System University of Turin